Inpatient hospitalization's associated cost and mortality in myeloma patients undergoing autologous stem cell transplant: a 13-year analysis of the National Inpatient Sample

被引:1
作者
Abbasi, Saqib [1 ]
Britt, Alec [1 ]
McClune, Brian [1 ]
Shune, Leyla [1 ]
Kambhampati, Suman [2 ]
Mohyuddin, Ghulam Rehman [1 ]
机构
[1] Univ Kansas, Med Ctr, Div Hematol Malignancies & Biomol Therapeut, Kansas City, KS 66103 USA
[2] Kansas City VA Med Ctr, Kansas City, KS USA
关键词
BONE-MARROW-TRANSPLANTATION; MULTIPLE-MYELOMA; SAFETY;
D O I
10.1080/10428194.2020.1719094
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1254 / 1256
页数:3
相关论文
共 14 条
[1]   Current status of autologous stem cell transplantation for multiple myeloma [J].
Al Hamed, Rama ;
Bazarbachi, Abdul Hamid ;
Malard, Florent ;
Harousseau, Jean-Luc ;
Mohty, Mohamad .
BLOOD CANCER JOURNAL, 2019, 9 (4)
[2]  
BARLOGIE B, 1986, BLOOD, V67, P1298
[3]   Autologous stem cell transplant in 716 patients with multiple myeloma: Low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative [J].
Gertz, Morfe A. ;
Ansell, Stephen M. ;
Dingli, David ;
Dispenzieri, Angela ;
Buadi, Francis K. ;
Elliott, Michelle A. ;
Gastineau, Dennis A. ;
Hayman, Suzanne R. ;
Hogan, William J. ;
Inwards, David J. ;
Johnston, Patrick B. ;
Kumar, Shaji ;
Lacy, Martha Q. ;
Leung, Nelson ;
Micallef, Ivana N. M. ;
Porrata, Luis F. ;
Schafer, Barbara A. ;
Wolf, Robert C. ;
Litzow, Mark R. .
MAYO CLINIC PROCEEDINGS, 2008, 83 (10) :1131-1135
[4]  
*HCUP AG HEALTHC R, 2002, HCUP NAT INP SAMPL N
[5]  
HCUP Fast Stats, 2019, HCUP FAST STAT
[6]   Safety and Cost-Effectiveness of Outpatient Autologous Stem Cell Transplantation in Patients with Multiple Myeloma [J].
Holbro, Andreas ;
Ahmad, Imran ;
Cohen, Sandra ;
Roy, Jean ;
Lachance, Silvy ;
Chagnon, Miguel ;
LeBlanc, Richard ;
Bernard, Lea ;
Busque, Lambert ;
Roy, Denis Claude ;
Sauvageau, Guy ;
Kiss, Thomas L. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (04) :547-551
[7]   Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today? [J].
Horton, Lucy E. ;
Haste, Nina M. ;
Taplitz, Randy A. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (01) :59-67
[8]  
Kodad SG, 2018, BIOL BLOOD MARROW TR, V24, pS39
[9]   Nationwide Trends of Severe Sepsis in the 21st Century (2000-2007) [J].
Kumar, Gagan ;
Kumar, Nilay ;
Taneja, Amit ;
Kaleekal, Thomas ;
Tarima, Sergey ;
McGinley, Emily ;
Jimenez, Edgar ;
Mohan, Anand ;
Khan, Rumi Ahmed ;
Whittle, Jeff ;
Jacobs, Elizabeth ;
Nanchal, Rahul .
CHEST, 2011, 140 (05) :1223-1231
[10]   Hematopoietic Stem Cell Transplantation and Implications for Cell Therapy Reimbursement [J].
Maziarz, Richard T. ;
Driscoll, Dawn .
CELL STEM CELL, 2011, 8 (06) :609-612